Prostate cancer: FDA panel recommends against approval for SonaCare's Sonablate

An FDA advisory panel votes against recommending approval for SonaCare Medical's Sonablate system to treat recurrent prostate cancer.

SonaCare Medical said it will reposition its Sonablate prostate cancer device to treat a more aggressive stage of the disease after an FDA panel last week failed to recommend approval for the device.

Food & Drug Administration (FDA), SonaCare Medical

News Well, Urology

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xig7bF